[Epidemiologic and laboratory assessments of etiologic implications of Blastocystis hominis in gastrointestinal diseases].
Authors present the first laboratory and epidemiological results which reveal the circulation in a population of protozoan Blastocystis hominis and its implication in the determinations of some gastrointestinal troubles, with fever, diarrhea and constipation, intense intestinal meteorism, associated with abdominal pain and cramps. Out of the 3106 investigated patients, 9.7% presented B. hominis as a unique etiologic agent, with an increased prevalence in adults (74.3%) and women (65.3%). Blastocystis infection with clinical manifestations or its asymptomatic form is included among emergent diseases.
Luca
Mariana
M
Universitatea de Medicina şi Farmacie Gr T Popa Iaşi, Facultatea de Medicină, Disciplina de Parazitologie.
Ivan
A
A
Goţia
Stela
S
Caşotă
Raluca-Elena
RE
Danciu
Viorica
V
D015746:Abdominal Pain / Q000469:parasitology; D000328:Adult; D017677:Age Distribution; D015766:Albendazole / Q000627:therapeutic use; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D016776:Blastocystis Infections / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology*; D016845:Blastocystis hominis / Q000302:isolation & purification*; D002648:Child; D003248:Constipation / Q000469:parasitology; D003967:Diarrhea / Q000469:parasitology; D005243:Feces / Q000469:parasitology; D005260:Female; D005334:Fever / Q000469:parasitology; D005767:Gastrointestinal Diseases / Q000188:drug therapy / Q000453:epidemiology* / Q000469:parasitology*; D006801:Humans; D008297:Male; D015995:Prevalence; D012189:Retrospective Studies; D012383:Romania / Q000453:epidemiology; D016896:Treatment Outcome
D000871:Anthelmintics; D015766:Albendazole